Furosemide - NDSRI's

NDSRI of Furosemide impurity-A

  • CAT NUMBER DCTI-C-3792
  • CAS NUMBER NA
  • MOLECULAR FORMULA C12H10ClN3O6S
  • MOLECULAR WEIGHT 359.74
References
FAQ's

References

  1. Salim, Edward F.; Haussler, A.; Vaughan, J. B., Qualitative and quantiative tests for Furosemide, Journal of Pharmaceutical Sciences, Volume: 57, Issue: 4, Pages: 640-1, 1968 DOI: (1002/jps.2600570420)
  2. Lindstrom, B., Determination of furosemide concentrations in plasma and urine using high-speed liquid chromatography, Journal of Chromatography, Volume: 100, Issue: 1, Pages: 189-91, 1974 DOI: (10.1016/s0021-9673(00)86055-0)
  3. Carr, Keith; Rane, Anders; Froelich, Juergen C., A simplified assay of furosemide in plasma and urine by high-pressure liquid chromatography, Journal of Chromatography, Biomedical Applications, Volume: 145, Issue: 3, Pages: 421-7, 1978 DOI: (1016/s0378-4347(00)81371-7)

Frequently Asked Questions

RP-HPLC helps identify and analyze Furosemide impurities.

Furosemide degradation products form under acid hydrolytic and photolytic conditions.

Preparative HPLC, LC/MS, and NMR can identify and isolate Furosemide degradation products.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart